INAB.NASDAQIn8bio, INC

Form 4: IN8BIO, INC.: Chief Operating Officer Kate Rochlin Awarded Stock Options

Sentiment:

SEC Form 4 Filing

📋All filings for In8bio, INC
🔒Login to Follow

Kate Rochlin, Chief Operating Officer of IN8BIO, INC., received a retention award of 250,000 stock options on September 4, 2024.

Summary

  • This Form 4 filing reports a change in beneficial ownership for Kate Rochlin, the Chief Operating Officer of IN8BIO, INC.
  • On September 4, 2024, Rochlin was granted 250,000 employee stock options as a retention award.
  • The exercise price of these options is $0.47 per share.
  • The options vest in installments: 25% on March 4, 2025, 25% on September 4, 2025, and 50% on March 4, 2026, contingent upon continued service.
  • Following this transaction, Rochlin beneficially owns 250,000 derivative securities (stock options).

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options is a positive sign for employee retention and alignment of interests, but it's a routine event.

Positives

  • The grant of stock options serves as a retention incentive for the Chief Operating Officer, aligning her interests with the long-term success of the company.

Future Outlook

The vesting schedule of the options is contingent upon the Reporting Person's continued service with the company.

Industry Context

Stock option grants are a common practice in the biotechnology industry to incentivize and retain key executives.

Stakeholder Impact

  • Shareholders may view the option grant as a positive incentive for management.
  • Employees may see this as a positive sign of investment in key personnel.

Key Dates

DateDescription
09/04/2024Date of transaction: Grant of stock options.
09/04/2024Date of exercisability of first tranche of options.
03/04/2025Date of first vesting tranche (25%).
09/04/2025Date of second vesting tranche (25%).
03/04/2026Date of final vesting tranche (50%).
09/04/2034Expiration date of the stock options.
09/05/2024Date of Form 4 signature.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.